Aspirin may lower the risk of colon cancer - Known as aspirin or painkillers could actually reduce a person's risk of colon cancer, says a new study. However, this effect seems limited to those without the genetic mutation associated with tumor risk.
"This study supports the use of aspirin for the prevention of colon cancer, but keep in mind that not all types of colon cancer can be treated equally and equitably," said study author Dr. Andrew Chan of Massachusetts General Hospital in Boston, as reported by CBS News.
Aspirin is a drug commonly used to reduce inflammation, pain, and muscle pain. Many people who take aspirin to prevent heart attacks and other heart problems.
Before this has been associated with aspirin is an anti-cancer agent. Research at Stanford University in March found that taking aspirin could reduce the risk of melanoma, which is a form of skin cancer is the most lethal. Research also suggests that aspirin may protect against liver and colon cancer, as well as reducing the risk of death from cancer.
However, other research has also linked aspirin with health problems. Several studies have shown that aspirin can increase the risk of age-related blindness and bleeding on the inside of the body.
Through the observation of two studies involving 127 865 people in 1980 until around 2012. Researchers found 1,200 cases of colon cancer during the study was run. They also found that regular aspirin intake associated with reduced risk of colon cancer by 27 percent. But this happens only in participants who were not associated with mutations in the BRAF gene. BRAF gene is a gene mutation that can cause normal cells into cancer cells.
The more aspirin are consumed every week, getting lower colon cancer risk is also owned by the participants. Through his research, Chan also found that colon cancer patients who took aspirin had a possibility to live longer than patients who did not take aspirin.
"This study supports the use of aspirin for the prevention of colon cancer, but keep in mind that not all types of colon cancer can be treated equally and equitably," said study author Dr. Andrew Chan of Massachusetts General Hospital in Boston, as reported by CBS News.
Aspirin is a drug commonly used to reduce inflammation, pain, and muscle pain. Many people who take aspirin to prevent heart attacks and other heart problems.
Before this has been associated with aspirin is an anti-cancer agent. Research at Stanford University in March found that taking aspirin could reduce the risk of melanoma, which is a form of skin cancer is the most lethal. Research also suggests that aspirin may protect against liver and colon cancer, as well as reducing the risk of death from cancer.
However, other research has also linked aspirin with health problems. Several studies have shown that aspirin can increase the risk of age-related blindness and bleeding on the inside of the body.
Through the observation of two studies involving 127 865 people in 1980 until around 2012. Researchers found 1,200 cases of colon cancer during the study was run. They also found that regular aspirin intake associated with reduced risk of colon cancer by 27 percent. But this happens only in participants who were not associated with mutations in the BRAF gene. BRAF gene is a gene mutation that can cause normal cells into cancer cells.
The more aspirin are consumed every week, getting lower colon cancer risk is also owned by the participants. Through his research, Chan also found that colon cancer patients who took aspirin had a possibility to live longer than patients who did not take aspirin.
